Ocrevus zunovo 920 MG-23,000 23ML

Ended Awarded

Contract number
SPE2DR26FRK7U
Awardee
Awarding agency
Obligated
$25,638

Award facts

Contract value 100% obligated
$25,637.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on July 13, 2026, for Ocrevus (ocrelizumab) 920 mg / 23 ml pharmaceutical supply, with a ceiling value of $25,637.70 and an ultimate completion date of August 3, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and vaccines to Department of Defense and federal healthcare systems under the DLA Troop Support Medical indefinite delivery contract vehicle.

Quick answers

Who was awarded contract SPE2DR26FRK7U?

SPE2DR26FRK7U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.

How much is contract SPE2DR26FRK7U worth?

The government has obligated $25,638 on SPE2DR26FRK7U.

Is contract SPE2DR26FRK7U an order under another contract?

Yes. SPE2DR26FRK7U is a delivery order under SPE2DR25D1022, an indefinite delivery contract.

Was contract SPE2DR26FRK7U competed?

The extent of competition for SPE2DR26FRK7U was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award